ArticleInfectious diseases of poverty2015
Are free anti-tuberculosis drugs enough? An empirical study from three cities in China.
Article in Infectious diseases of poverty, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Challenge of ending TB in China: tuberculosis control in primary healthcare sectors under integrated TB control model-a systematic review and meta-analysis.BMC public health · 2024Pooled it
- Latent Class Analysis of Medication Adherence and Its Influencing Factors Among Rural Hypertensive Patients in Shanxi Province, China.Patient preference and adherence · 2026Article
- Economic-Clinical Burdens of Tuberculosis Treatment in Vulnerable Patients in a Provincial General Referral Hospital in Lubumbashi, DR Congo.ClinicoEconomics and outcomes research : CEOR · 2026Article
- Household economic burden and catastrophic expenditures in non-resistant tuberculosis patients: cross-sectional survey in Guizhou, China.Frontiers in public health · 2025Article
- Tuberculosis in older adults: case studies from four countries with rapidly ageing populations in the western pacific region.BMC public health · 2023Article
- The Association Between Household Financial Burden and Patient Mobility and Their Impact on Loss to Follow-Up Among Multidrug-Resistant Tuberculosis Patients in Guizhou, China.Risk management and healthcare policy · 2023Article
- Disparity in socio-economic status explains the pattern of self-medication of antibiotics in India: understanding from game-theoretic perspective.Royal Society open science · 2022Article
- The impact of ethnic minority status on tuberculosis diagnosis and treatment delays in Hunan Province, China.BMC infectious diseases · 2022Article
- Evaluation of Mobile Application for the Management of Tuberculosis Patients in Tianjin During 2019-2020.Patient preference and adherence · 2022Article
- Impacts of Medical Security Level on Treatment Outcomes of Drug-Resistant Tuberculosis: Evidence from Wuhan City, China.Patient preference and adherence · 2022Article
- Association of migration status with quality of life among rural and urban adults with rare diseases: A cross-sectional study from China.Frontiers in public health · 2022Article
- How and to what extent can pensions facilitate increased use of health services by older people: evidence from social pension expansion in rural China.BMC health services research · 2020Article
- Out-of-pocket payments and economic consequences from tuberculosis care in eastern China: income inequality.Infectious diseases of poverty · 2020Article
- Challenges Faced by Multidrug-Resistant Tuberculosis Patients in Three Financially Affluent Chinese Cities.Risk management and healthcare policy · 2020Article
- Factors Influencing Medication Nonadherence to Pulmonary Tuberculosis Treatment in Tibet, China: A Qualitative Study from the Patient Perspective.Patient preference and adherence · 2020Article
- Analysis of the economic burden of diagnosis and treatment on patients with tuberculosis in Bao'an district of Shenzhen City, China.PloS one · 2020Article
- Role of Treatment Adherence, Doctor-Patient Trust, and Communication in Predicting Treatment Effects Among Tuberculosis Patients: Difference Between Urban and Rural Areas.Patient preference and adherence · 2020Article
- Experiences of Latent Tuberculosis Infection Treatment for the North Korean Refugees.Tuberculosis and respiratory diseases · 2019Article
- The Effect of an Innovative Financing and Payment Model for Tuberculosis Patients on Health Service Utilization in China: Evidence from Hubei Province of China.International journal of environmental research and public health · 2019Article
- Impact of an innovative tuberculosis financing and payment model on health service utilization by tuberculosis patients in China: do the poor fare better than the rich?Infectious diseases of poverty · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTuberculosis (TB) patients in China still face a number of barriers in seeking diagnosis and treatment. There is evidence that the economic burden on TB patients and their households discourages treatment compliance.
methodsA cross-sectional study was conducted in three cities of China. Patients were selected using probability proportional to size (PPS) cluster sampling of rural townships or urban streets, followed by list sampling from a patient register. Data were collected using a questionnaire survey, key informant interviews and focus group discussions with TB patients to gain an understanding of the economic burden of TB and implications of this burden for treatment compliance.
resultsA total of 797 TB patients were surveyed, of which 60 were interviewed in-depth following the survey. More than half had catastrophic health expenditure. TB patients with higher household incomes were less likely to report non-compliance (OR 0.355, 95 % CI 0.140-0.830) and patients who felt that the economic burden relating to TB treatment was high more likely to report non-compliance (OR 3.650, 95 % CI 1.278-12.346). Those who had high costs for transportation, lodging and food were also more likely to report non-compliance (OR 4.150, 95 % CI 1.804-21.999). The findings from the qualitative studies supported those from the survey.
conclusionThe economic burden associated with seeking diagnosis and treatment remains a barrier for TB patients in China. Reducing the cost of treatment and giving patients subsidies for transportation, lodging and food is likely to improve treatment compliance. Improving doctors' salary system to cut off the revenue-oriented incentive, and expanding current insurance's coverage can be helpful to reduce patients' actual burden or anticipated burden. Future research on this issue is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.